In this episode of the Psychedelic Spotlight podcast, we catch up with Daniel Carcillo, Founder, and CEO of Wesana Health, to talk about the company’s recent listing on the #CSE, their plans to uplist to the NASDAQ, and their recently formed partnership with the University of South Carolina and what it means for the development of more effective treatments for TBI.
*To learn more about the company featured in this interview and the work they’re doing, visit their website: https://www.wesanahealth.com
*Get the latest industry news around all things psychedelics by visiting our website, and be sure to subscribe to our newsletter to never miss a thing.
Subscribe to our YouTube channel: https://bit.ly/3prTiCI
Visit our Website: https://psychedelicspotlight.com
Follow us on Instagram: https://instagram.com/psycspotlight
Like us on Facebook: https://facebook.com/PsychedelicSpotlight
Follow us on Twitter: https://twitter.com/PsycSpotlight
*This interview was recorded on July 7, 2021.
#psychedelics #mushrooms #wesana #wesanahealth #psilocybin #news #business #stocks #NASDAQ #SouthCarolina #TBI
source
Psychedelic Spotlight is your reliable source for the latest stories in the emerging psychedelics industry, covering breakthrough discoveries, investor news and cultural reform.
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.
